19 Facts About Trudie Lang

Trudie Lang is a Professor of Global Health Research at the University of Oxford.

Trudie Lang later worked in Kenya as Head of the Kilifi Clinical Trial Facility at the KEMRI-Wellcome Trust Research Programme.

Trudie Lang then moved to the Nuffield Department of Medicine, University of Oxford, where she is currently Professor of Global Health Research in the Centre for Tropical Medicine and Global Health.

Trudie Lang was promoted to Professor in 2014 and is a Senior Research Fellow of Green Templeton College.

Trudie Lang's work has focused on improving clinical trials in low and middle-income countries, including training of clinical teams, strengthening regulatory protocols, and resource sharing.

Related searches

Trudie Lang has led on training and capacity development programmes, including one with Palmer Masumbe Netongo, to support research within the African Coalition for Epidemic Research, Capacity, and Training.

Trudie Lang led on a collaborative project with the University of Liverpool to improve the management of brain infections.

In 2014, Trudie Lang helped organise a clinical trial for the drug brincidofovir during the Ebola virus outbreak in Liberia.

Trudie Lang advocated against randomised controlled trials in this specific outbreak, arguing that this model was not appropriate when there was already mistrust of health systems and people were desperate to access medication.

Trudie Lang took charge of liaising with regulators and the drug company in order to start the trial as quickly as possible.

Trudie Lang briefed US White House officials on the progress of clinical research during the Ebola outbreak.

Alongside her research, Trudie Lang has advised the UK government on various areas of global health.

Trudie Lang highlighted the importance of being prepared to undertake research during emerging outbreaks, and the importance of coordination between research groups.

Trudie Lang provided information about the unique regulatory and approval process for the Ebola clinical trials.

Trudie Lang has provided expert opinion in many media outlets on topics including Ebola virus, Zika virus, epidemic management, and SARS-CoV2.

Trudie Lang has advocated for better: clinical trial protocols, training of researchers and coordination between research groups in order to be better prepared for future outbreaks.

Trudie Lang was cited as an expert in helping inform the British public during the 2020 SAR-CoV2 pandemic.

Trudie Lang has engaged in outreach with the wider public, giving talks on malaria and emerging diseases, including Zika and Ebola.

Trudie Lang is Director of the Global Health Network, a digital platform for researchers in global health.